EDAP TMS S.A. EDAP | $53.12M | 19.48 | 7.23M | +0.01% | +$7,438.20 | 0.51 | |
| NeuroPace, Inc. NPCE | $32.12M | 8.46 | 2.43M | 0% | +$0 | 0.31 | |
| BioAtla, Inc. BCAB | $13.98M | 8.45 | 4.07M | 0% | +$0 | 0.13 | |
| Immunic, Inc. IMUX | $9.63M | 8.1 | 7.29M | +2,331% | +$9.23M | 0.09 | |
| ESSA Pharma Inc. EPIX | $30.48M | 8.09 | 3.59M | -17.05% | -$6.27M | 0.29 | |
Jasper Therapeutics, Inc. JSPR | $34.85M | 7.87 | 1.19M | -87.97% | -$254.96M | 0.33 | |
| Organogenesis Holdings Inc. ORGO | $27.19M | 7.22 | 9.57M | +6.81% | +$1.73M | 0.26 | |
| AxoGen, Inc. AXGN | $25.06M | 7.11 | 3.11M | +19.65% | +$4.12M | 0.24 | |
| Verastem, Inc. VSTM | $18.18M | 6.08 | 1.54M | +8.07% | +$1.36M | 0.17 | |
| Surmodics, Inc. SRDX | $23.5M | 5.62 | 800,820 | +3.77% | +$854,380.81 | 0.22 | |
| Celcuity Inc. CELC | $37.4M | 5.54 | 1.73M | -20.56% | -$9.68M | 0.36 | |
| Rigel Pharmaceuticals, Inc. RIGL | $13.68M | 5.27 | 9.24M | -2.12% | -$296,877.63 | 0.13 | |
| C4 Therapeutics, Inc. CCCC | $20.09M | 3.57 | 2.46M | +33.93% | +$5.09M | 0.19 | |
GeneDx Holdings Corp. WGS | $7.15M | 3 | 783,376 | +1,205.63% | +$6.6M | 0.07 | |
| IRadimed Corporation IRMD | $15.91M | 2.86 | 361,630 | -43.78% | -$12.39M | 0.15 | |
| Enanta Pharmaceuticals, Inc. ENTA | $10.14M | 2.74 | 580,546 | New | +$10.14M | 0.1 | |
| Castle Biosciences, Inc. CSTL | $16.07M | 2.63 | 725,457 | +2,690.22% | +$15.49M | 0.15 | |
| Treace Medical Concepts, Inc. TMCI | $17.56M | 2.17 | 1.35M | +32.71% | +$4.33M | 0.17 | |
| TG Therapeutics, Inc. TGTX | $48.19M | 2.05 | 3.17M | +387.45% | +$38.31M | 0.46 | |
| Nurix Therapeutics, Inc. NRIX | $16.39M | 1.88 | 1.11M | +679.72% | +$14.29M | 0.16 | |
Mereo BioPharma Group plc MREO | $8.64M | 1.87 | 2.62M | -73.23% | -$23.63M | 0.08 | |
| Applied Therapeutics, Inc. APLT | $10.64M | 1.37 | 1.56M | +239.61% | +$7.51M | 0.1 | |
| Y-mAbs Therapeutics, Inc. YMAB | $9.28M | 1.3 | 570,982 | +263.26% | +$6.73M | 0.09 | |
| Tango Therapeutics, Inc. TNGX | $10.72M | 1.26 | 1.35M | +59.38% | +$3.99M | 0.1 | |
| Iovance Biotherapeutics, Inc. IOVA | $51.94M | 1.25 | 3.5M | +531.53% | +$43.72M | 0.5 | |
| Olema Pharmaceuticals, Inc. OLMA | $7.45M | 1.18 | 658,000 | New | +$7.45M | 0.07 | |
| Keros Therapeutics, Inc. KROS | $18.11M | 0.76 | 273,600 | New | +$18.11M | 0.17 | |
Pharvaris N.V. PHVS | $9.29M | 0.75 | 401,901 | +84.87% | +$4.26M | 0.09 | |
| IDEAYA Biosciences, Inc. IDYA | $23.41M | 0.71 | 533,515 | -5.52% | -$1.37M | 0.22 | |
| NovoCure Limited NVCR | $10.87M | 0.65 | 695,759 | +131.15% | +$6.17M | 0.1 | |
| United Therapeutics Corporation UTHR | $59.67M | 0.59 | 259,749 | +4.13% | +$2.37M | 0.57 | |
| Inari Medical, Inc. NARI | $13.29M | 0.48 | 277,000 | New | +$13.29M | 0.13 | |
| Revolution Medicines, Inc. RVMD | $23.49M | 0.44 | 728,700 | +189.17% | +$15.36M | 0.22 | |
| Syndax Pharmaceuticals, Inc. SNDX | $8.78M | 0.43 | 369,000 | -28.21% | -$3.45M | 0.08 | |
| Merus N.V. MRUS | $8.81M | 0.33 | 195,577 | -35.36% | -$4.82M | 0.08 | |
CG Oncology, Inc. Common stock CGON | $9.56M | 0.33 | 217,871 | New | +$9.56M | 0.09 | |
| Teva Pharmaceutical Industries Limited TEVA | $49.19M | 0.31 | 3.49M | -37.34% | -$29.32M | 0.47 | |
| Krystal Biotech, Inc. KRYS | $14.96M | 0.29 | 84,100 | +110.25% | +$7.85M | 0.14 | |
| Arcellx, Inc. ACLX | $10.43M | 0.28 | 150,000 | -5.66% | -$625,950.00 | 0.1 | |
| Penumbra, Inc. PEN | $19.13M | 0.22 | 85,700 | +7.93% | +$1.41M | 0.18 | |
| Nuvalent, Inc. NUVL | $9.71M | 0.2 | 129,288 | -59.96% | -$14.54M | 0.09 | |
| Vaxcyte, Inc. PCVX | $14.19M | 0.19 | 207,750 | -49.99% | -$14.19M | 0.14 | |
| Immunovant, Inc. IMVT | $8.55M | 0.18 | 264,650 | -16.53% | -$1.69M | 0.08 | |
Natera, Inc. NTRA | $7.96M | 0.07 | 87,000 | New | +$7.96M | 0.08 | |
| Humana Inc. HUM | $24.97M | 0.06 | 72,006 | -2.31% | -$589,423.99 | 0.24 | |
| Biogen Inc. BIIB | $15.7M | 0.05 | 72,800 | New | +$15.7M | 0.15 | |
| HCA Healthcare, Inc. HCA | $17.16M | 0.02 | 51,441 | -49.32% | -$16.7M | 0.16 | |
GSK plc GSK | $13.68M | 0.02 | 319,217 | -75.03% | -$41.13M | 0.13 | |
| BeiGene, Ltd. BGNE | $23.16M | 0.01 | 148,100 | New | +$23.16M | 0.22 | |
| Inhibrx, Inc. INBX | $9.36B | <0.01 | 267,871 | +1,685.81% | +$8.84B | 89.48 |